BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 31436356)

  • 21. Clonal hematopoiesis of indeterminate potential-associated mutations and risk of comorbidities in patients with myelodysplastic syndrome.
    Naqvi K; Sasaki K; Montalban-Bravo G; Alfonso Pierola A; Yilmaz M; Short N; Assi R; Jabbour E; Ravandi F; Kadia T; Pierce S; Takahashi K; Nogueras Gonzalez G; Kanagal-Shamanna R; Patel K; Soltysiak KA; Kantarjian HM; Garcia-Manero G
    Cancer; 2019 Jul; 125(13):2233-2241. PubMed ID: 30861111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lineage restriction analyses in CHIP indicate myeloid bias for
    Buscarlet M; Provost S; Zada YF; Bourgoin V; Mollica L; Dubé MP; Busque L
    Blood; 2018 Jul; 132(3):277-280. PubMed ID: 29764839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical aspects of TP53 gene inactivation in diffuse large B-cell lymphoma.
    Voropaeva EN; Pospelova TI; Voevoda MI; Maksimov VN; Orlov YL; Seregina OB
    BMC Med Genomics; 2019 Mar; 12(Suppl 2):35. PubMed ID: 30871527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of plasma cell-free DNA for
    Gutierrez-Rodrigues F; Beerman I; Groarke EM; Patel BA; Spitofsky N; Dillon LW; Raffo DQ; Hourigan CS; Kajigaya S; Ferrucci L; Young NS
    Haematologica; 2022 Aug; 107(8):1815-1826. PubMed ID: 34587721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular tumor analysis and liquid biopsy: a feasibility investigation analyzing circulating tumor DNA in patients with central nervous system lymphomas.
    Hickmann AK; Frick M; Hadaschik D; Battke F; Bittl M; Ganslandt O; Biskup S; Döcker D
    BMC Cancer; 2019 Mar; 19(1):192. PubMed ID: 30823914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive landscape and interference of clonal haematopoiesis mutations for liquid biopsy: A Chinese pan-cancer cohort.
    Xu E; Su K; Zhou Y; Gong L; Xuan Y; Liao M; Cao J; Li Y; Lu Y; Zhao Y; Chen F
    J Cell Mol Med; 2021 Nov; 25(21):10279-10290. PubMed ID: 34658138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MYD88, CARD11, and CD79B Oncogenic Mutations are Rare Events in the Indian Cohort of De Novo Nodal Diffuse Large B-Cell Lymphoma.
    Aggarwal V; Das A; Bal A; Srinivasan R; Das R; Prakash G; Malhotra P; Varma S
    Appl Immunohistochem Mol Morphol; 2019 Apr; 27(4):311-318. PubMed ID: 29734251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory cytokines promote clonal hematopoiesis with specific mutations in ulcerative colitis patients.
    Zhang CRC; Nix D; Gregory M; Ciorba MA; Ostrander EL; Newberry RD; Spencer DH; Challen GA
    Exp Hematol; 2019 Dec; 80():36-41.e3. PubMed ID: 31812712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and dynamics of clonal hematopoiesis caused by leukemia-associated mutations in elderly individuals without hematologic disorders.
    Midic D; Rinke J; Perner F; Müller V; Hinze A; Pester F; Landschulze J; Ernst J; Gruhn B; Matziolis G; Heidel FH; Hochhaus A; Ernst T
    Leukemia; 2020 Aug; 34(8):2198-2205. PubMed ID: 32457355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promoter hypermethylation of the DNA-repair gene O6-methylguanine-DNA methyltransferase and p53 mutation in diffuse large B-cell lymphoma.
    Hiraga J; Kinoshita T; Ohno T; Mori N; Ohashi H; Fukami S; Noda A; Ichikawa A; Naoe T
    Int J Hematol; 2006 Oct; 84(3):248-55. PubMed ID: 17050200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequent genetic alterations in immune checkpoint-related genes in intravascular large B-cell lymphoma.
    Shimada K; Yoshida K; Suzuki Y; Iriyama C; Inoue Y; Sanada M; Kataoka K; Yuge M; Takagi Y; Kusumoto S; Masaki Y; Ito T; Inagaki Y; Okamoto A; Kuwatsuka Y; Nakatochi M; Shimada S; Miyoshi H; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Shiozawa Y; Nannya Y; Okabe A; Kohno K; Atsuta Y; Ohshima K; Nakamura S; Ogawa S; Tomita A; Kiyoi H
    Blood; 2021 Mar; 137(11):1491-1502. PubMed ID: 33512416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-free DNA as a biomarker in diffuse large B-cell lymphoma: A systematic review.
    Arzuaga-Mendez J; Prieto-Fernández E; Lopez-Lopez E; Martin-Guerrero I; García-Ruiz JC; García-Orad A
    Crit Rev Oncol Hematol; 2019 Jul; 139():7-15. PubMed ID: 31112884
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Vitale SR; Groenendijk FH; van Marion R; Beaufort CM; Helmijr JC; Dubbink HJ; Dinjens WNM; Ewing-Graham PC; Smolders R; van Doorn HC; Boere IA; Berns EMJJ; Helleman J; Jansen MPHM
    Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32156073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustained clonal hematopoiesis by HLA-lacking hematopoietic stem cells without driver mutations in aplastic anemia.
    Imi T; Katagiri T; Hosomichi K; Zaimoku Y; Hoang Nguyen V; Nakagawa N; Tajima A; Yoshizato T; Ogawa S; Nakao S
    Blood Adv; 2018 May; 2(9):1000-1012. PubMed ID: 29720492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations.
    Assmus B; Cremer S; Kirschbaum K; Culmann D; Kiefer K; Dorsheimer L; Rasper T; Abou-El-Ardat K; Herrmann E; Berkowitsch A; Hoffmann J; Seeger F; Mas-Peiro S; Rieger MA; Dimmeler S; Zeiher AM
    Eur Heart J; 2021 Jan; 42(3):257-265. PubMed ID: 33241418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal Hematopoiesis.
    Kim R; Bergugnat H; Larcher L; Duchmann M; Passet M; Gachet S; Cuccuini W; Lafage-Pochitaloff M; Pastoret C; Grardel N; Asnafi V; Schäfer BW; Delabesse E; Itzykson R; Adès L; Hicheri Y; Chalandon Y; Graux C; Chevallier P; Hunault M; Leguay T; Huguet F; Lhéritier V; Dombret H; Soulier J; Rousselot P; Boissel N; Clappier E
    Blood Cancer Discov; 2023 Mar; 4(2):134-149. PubMed ID: 36630200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Clonal Hematopoiesis in DNA Repair Genes With Prostate Cancer Plasma Cell-free DNA Testing Interference.
    Jensen K; Konnick EQ; Schweizer MT; Sokolova AO; Grivas P; Cheng HH; Klemfuss NM; Beightol M; Yu EY; Nelson PS; Montgomery B; Pritchard CC
    JAMA Oncol; 2021 Jan; 7(1):107-110. PubMed ID: 33151258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent DNMT3A mutation burden in DNMT3A mutated adult cytogenetically normal acute myeloid leukemia patients in long-term remission.
    Sun Y; Shen H; Xu T; Yang Z; Qiu H; Sun A; Chen S; Wu D; Xu Y
    Leuk Res; 2016 Oct; 49():102-7. PubMed ID: 27626217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Droplet digital polymerase chain reaction for detection and quantification of cell-free DNA TP53 target somatic mutations in oral cancer.
    Lin LH; Cheng HW; Liu CJ
    Cancer Biomark; 2022; 33(1):29-41. PubMed ID: 34366328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statistical analysis of mutant allele frequency level of circulating cell-free DNA and blood cells in healthy individuals.
    Xia L; Li Z; Zhou B; Tian G; Zeng L; Dai H; Li X; Liu C; Lu S; Xu F; Tu X; Deng F; Xie Y; Huang W; He J
    Sci Rep; 2017 Aug; 7(1):7526. PubMed ID: 28790338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.